Ashton Frulla
Adult Health · Boston, MANPI 1235657560
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.3% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,394 and has fallen 65.1% since, to $487 in 2025. Among adult health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Incyte Corporation$533
- Regeneron Healthcare Solutions, Inc.$506
- Johnson & Johnson$499
- E.r. Squibb & Sons, L.L.C.$294
- Sun Pharmaceutical Industries Inc.$281
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,20990%
- Education$45310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,034 |
| Incyte Corporation | 43 | $533 |
| Regeneron Healthcare Solutions, Inc. | 16 | $506 |
| Johnson & Johnson | 14 | $499 |
| E.r. Squibb & Sons, L.L.C. | 13 | $294 |
| Sun Pharmaceutical Industries Inc. | 15 | $281 |
| Pfizer | 9 | $233 |
| Sanofi | 6 | $161 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $133 |
| Novartis | 5 | $132 |
| Galderma Laboratories, L.p. | 7 | $121 |
| LEO Pharma Inc. | 6 | $120 |
| Lilly USA, LLC | 5 | $116 |
| UCB, Inc. | 4 | $93 |
| Almirall LLC | 4 | $87 |
| Amgen | 4 | $79 |
| EPI Health, LLC | 4 | $79 |
| Dermavant Sciences, Inc. | 2 | $45 |
| VYNE Pharmaceuticals Inc. | 2 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| Mission Pharmacal Company | 1 | $16 |
How this compares
$4,662 in reported general payments places this provider in the 95th percentile of 671 adult health providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $50,382 |
| Ketoconazole | 16 | $248 |
| Triamcinolone Acetonide | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other adult health in Boston
- Krista TuckerBoston$157K
- Christine AgiusBoston$32K
- Josie BazemoreBoston$22K
- Kathryn SchochBoston$11K
- Megan MaysBoston$8K
- Bonnie DirrBoston$8K
- Julie SheaBoston$7K
- Elyse MandellBoston$7K
- Sarah KennedyBoston$6K
- Virginia SeeryBoston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.